Latest News and Press Releases

29 April 2026, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR BUSINESS HIGHLIGHTS 2025 EPH European Property Holdings PLC (“EPH” or the “Company”) has continued to achieve stable...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...

GRAND-LANCY, Switzerland, April 28, 2026 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), a global leader in banking technology, today announced it has been named a Leader in the Forrester Wave™: Digital...

Pratteln, Switzerland, April 28, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces that the Board of Directors of the Italian Medicines Agency, AIFA, has approved the reimbursement of AGAMREE®...

Pratteln, Schweiz, 28. April 2026 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass der Vorstand der italienischen Arzneimittelbehörde AIFA die Erstattung von AGAMREE® (Vamorolon) für die...

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT. Details are at the end of this news release AGAMREE® delivers...

Ad-hoc-Mitteilung gemäss Art. 53 KR. Am 28. April 2026 findet um 14:00 Uhr MESZ / 13:00 Uhr BST / 08:00 Uhr EDT eine Telefonkonferenz statt. Einzelheiten finden Sie am Ende dieser Pressemitteilung ...

Ad hoc announcement pursuant to Art. 53 LR Preparation is underway to publish the strong pediatric daridorexant data and engage with regulatory authorities on next stepsCo-promotion of QUVIVIQ is...

Ad hoc announcement pursuant to Art. 53 LRFirst quarterNet sales declined -5% (cc1, -1% USD), as growth drivers were more than offset by US generic erosionContinued strong performance from priority...

Ad-hoc-Mitteilung gemäss Art. 53 KR   Erstes QuartalDer Nettoumsatz ging um –5% (kWk1, –1% USD) zurück, da Wachstumstreiber durch Einbussen durch Generika in den USA mehr als aufgehoben...